Surgery for oligometastatic non–small cell lung cancer Editorial


Authors: Antonoff, M. B.; Deboever, N.; Werner, R.; Altan, M.; Gomez, D.; Opitz, I.
Title: Surgery for oligometastatic non–small cell lung cancer
Keywords: treatment outcome; overall survival; multimodality cancer therapy; patient selection; cancer staging; evidence based medicine; ipilimumab; progression free survival; lung resection; carcinoma, non-small-cell lung; lung neoplasms; pneumonectomy; local therapy; editorial; pathology; lung tumor; clinical evaluation; surgery; non small cell lung cancer; anaplastic lymphoma kinase; randomized controlled trial (topic); phase 2 clinical trial (topic); phase 3 clinical trial (topic); phase 1 clinical trial (topic); clinical outcome; european; egfr signaling; combination drug therapy; consolidation chemotherapy; nivolumab; humans; human; brigatinib; osimertinib; north american; oligometastatic; non–small cell lung cancer; local consolidative therapy; oligometastatic non-small cell lung cancer
Journal Title: Journal of Thoracic and Cardiovascular Surgery
Volume: 167
Issue: 2
ISSN: 0022-5223
Publisher: Mosby Elsevier  
Date Published: 2024-02-01
Start Page: 508
End Page: 516.e1
Language: English
DOI: 10.1016/j.jtcvs.2023.09.048
PUBMED: 37778504
PROVIDER: scopus
DOI/URL:
Notes: Editorial -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Daniel R Gomez
    237 Gomez